Botulism: Update and Review

 

 Buy Article Permissions and Reprints

Botulism is both an old and an emerging disease. Over 100 years ago, the classic food-borne type was found to be caused by ingesting contaminated food containing the toxin produced by a bacteria. In the first half of the 20th century a second form, wound botulism, was discovered. Three additional forms (infant, hidden, and inadvertent) were first described in the last quarter of the 20th century. Our understanding of how botulinum toxin blocks the release of acetylcholine at the neuromuscular junction has been clarified in the past 10 years. In the past 20 years, we have witnessed one of the strangest of all ironies in the history of medicine. The very lethal botulinum toxin is now being used as a treatment in an expanding list of disorders. Research is advancing in several directions. These new avenues include improved methods of preventing and treating botulism and additional novel uses of botulinum toxin as a therapeutic agent. In this article, the five clinical forms of botulism, the actions of botulinum toxins, electrodiagnostic methods, treatments, and possible future directions are discussed.

REFERENCES

• 1 Cherington M. Clinical spectrum of botulism.  Muscle Nerve. 1998;  21 701-710
  PubMedGoogle Scholar
• 2 Scott A B. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.  J Pediatr Ophthalmol Strabismus. 1980;  17 21-25
  PubMedGoogle Scholar
• 3 Chang M, Glynn K, Groseclose S L. Endemic, notifiable bioterrorism-related diseases, Unites States 1992-1999.  Emerg Infect Dis. 2003;  9 556-564
  PubMedGoogle Scholar
• 4 Han S Z, Alfano M C, Psoter W J, Rekow E D. Bioterrorism and catastrophe response.  J Am Dent Assoc. 2003;  134 745-752
  PubMedGoogle Scholar
• 5 Lamanna C. The most poisonous poison.  Science. 1959;  130 763-772
  PubMedGoogle Scholar
• 6 Burningham M D, Walter F G, Mechem C et al.. Wound botulism.  Ann Emerg Med. 1994;  24 1184-1187
  PubMedGoogle Scholar
• 7 Hughes J M. Botulism. In: Scheid WM, Whitley RJ, Durack DT Infections of the Central Nervous System. New York; Raven Press 1991: 150-153
  Google Scholar
• 8 Schantz E J, Johnson E A. Botulinum toxin: the story of its development for the treatment of human disease.  Perspect Biol Med. 1997;  40 317-327
  PubMedGoogle Scholar
• 9 Foran P G, Davletov B, Meunier F A. Getting muscles moving again after botulinum toxin: novel therapeutic challenges.  Trends Mol Med. 2003;  9 291-298
  CrossrefPubMedGoogle Scholar
• 10 Maselli R A. Pathogenesis of human botulism.  Ann N Y Acad Sci. 1998;  841 122-139
  PubMedGoogle Scholar
• 11 Schiavo G, Benfenati F, Poulain B et al.. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.  Nature. 1992;  359 832-835
  CrossrefPubMedGoogle Scholar
• 12 Barnes M. Botulinum toxin: mechanisms of action and clinical use in spasticity.  J Rehabil Med. 2003;  41(suppl) 56-59
  PubMedGoogle Scholar
• 13 Cherington M. Botulism: ten year experience.  Arch Neurol. 1974;  30 432-437
  PubMedGoogle Scholar
• 14 Woodruff B A, Griffin P M, McCroskey L M et al.. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States 1975-1988.  J Infect Dis. 1992;  166 1281-1286
  PubMedGoogle Scholar
• 15 Beller M. Available at: www.phppo.cdc.gov/phtn/botulism/alaska/alaska.asp Accessed 2003
• 16 Townes J M, Cieslak P R, Hatheway C L et al.. An outbreak of type A botulism associated with a commercial cheese sauce.  Ann Intern Med. 1996;  125 558-563
  PubMedGoogle Scholar
• 17 Shapiro R L, Hatheway C, Becher J, Swerdlow D L. Botulism surveillance and emergency response.  JAMA. 1997;  278 433-435
  CrossrefPubMedGoogle Scholar
• 18 Hayes M T, Soto O, Ruoff K L. Case records of the Massachusetts General Hospital: case 22-1997.  N Engl J Med. 1997;  337 184-190
  CrossrefPubMedGoogle Scholar
• 19 Angulo F J, Getz J, Taylor J P et al.. A large outbreak of botulism: the hazardous baked potato.  J Infect Dis. 1998;  178 172-177
  PubMedGoogle Scholar
• 20 Brown L W. Infant botulism.  Adv Pediatr. 1981;  28 141-157
  PubMedGoogle Scholar
• 21 Goode G B, Shearn D L. Botulism. A case with associated sensory abnormalities.  Arch Neurol. 1982;  39 55
  PubMedGoogle Scholar
• 22 Kuruoglu R, Cengiz B, Tokcaer A. Botulism with sensory symptoms diagnosed by neuromuscular transmission studies associated with edrophonium responsiveness.  Electromyogr Clin Neurophysiol. 1996;  36 477-480
  PubMedGoogle Scholar
• 23 Martinez-Castrillo J D, Del Real M A, Hernandex Gonzalez A et al.. Botulism with sensory symptoms: a second case.  J Neurol Neurosurg Psychiatry. 1991;  54 844-845
  PubMedGoogle Scholar
• 24 Girlanda P, Vita G, Nicolosi C et al.. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system.  J Neurol Neurosurg Psychiatry. 1992;  55 844-845
  CrossrefPubMedGoogle Scholar
• 25 Jenzer G, Mumenthaler M, Ludin H P, Robert F. Autonomic dysfunction in botulism B: a clinical report.  Neurology. 1975;  25 150-153
  PubMedGoogle Scholar
• 26 Chen J T, Chen C C, Lin K P et al.. Botulism: heart rate variation, sympathetic skin responses, and plasma norepinephrine.  Can J Neurol Sci. 1999;  26 123-126
  PubMedGoogle Scholar
• 27 Duchen L W, Strich S J. The effects of botulism toxin on the pattern of innervation of skeletal muscle in the mouse.  Q J Exp Physiol Cogn Med Sci. 1968;  53 84-89
  PubMedGoogle Scholar
• 28 Eleopra R, Tugnoli V, Rossetto O et al.. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.  Neurosci Lett. 1998;  256 135-138
  CrossrefPubMedGoogle Scholar
• 29 Uncini A, Lugarosi A. Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block.  Muscle Nerve. 1999;  22 640-644
  PubMedGoogle Scholar
• 30 Shapiro B E, Soto O, Shafqat S, Blumenfeld H. Adult botulism.  Muscle Nerve. 1997;  20 100-102
  CrossrefPubMedGoogle Scholar
• 31 Cherington M. Electrophysiologic methods as an aid in diagnosis of botulism: a review.  Muscle Nerve. 1982;  5 S28-S29
  PubMedGoogle Scholar
• 32 Ryan D W, Cherington M. Human type A botulism.  JAMA. 1971;  216 513-514
  CrossrefPubMedGoogle Scholar
• 33 Edell T A, Sullivan C P, Osborn K M et al.. Wound botulism associated with a positive tensilon test.  West J Med. 1983;  139 218-219
  PubMedGoogle Scholar
• 34 Pickett J B, Berg B, Chaplin E, Brunstetter-Shafer M A. Syndrome of botulism in infancy: clinical and electrophysiologic study.  N Engl J Med. 1976;  295 770-772
  PubMedGoogle Scholar
• 35 Arnon S S. Infant botulism: anticipating the second decade.  J Infect Dis. 1986;  154 201-205
  PubMedGoogle Scholar
• 36 Schmidt R D, Schmidt T W. Infant botulism: a case series and review of the literature.  J Emerg Med. 1992;  10 713-718
  CrossrefPubMedGoogle Scholar
• 37 Kothare S V, Kassner E G. Infant botulism: a rare cause of colonic ileus.  Pediatr Radiol. 1995;  25 24-26
  PubMedGoogle Scholar
• 38 Tanki M G, Gabay M P. Association between honey consumption and infant botulism.  Pharmacotherapy. 2002;  22 1479-1483
  CrossrefPubMedGoogle Scholar
• 39 Ravid S, Maytal J, Eviatar L. Biphasic course of infant botulism.  Pediatr Neurol. 2000;  23 338-340
  CrossrefPubMedGoogle Scholar
• 40 Schechter R. Infant botulism: a brief overview.  Anaerobe. 1999;  5 161-164
  CrossrefPubMedGoogle Scholar
• 41 Underwook K, Deakers T W, Newth C J, Mitchell W G. Infant botulism: a 26-year experience in the pediatric intensive care unit.  Crit Care Med. 2003;  31(suppl) , Abstract 531
  PubMedGoogle Scholar
• 42 Bennett A M, Perkins S D, Holley J L. DNA vaccination protects against botulinum neurotoxin F.  Vaccine. 2003;  21 3110-3117
  CrossrefPubMedGoogle Scholar
• 43 Midura T F. Update: infant botulism.  Clin Microbiol Rev. 1996;  9 119-125
  PubMedGoogle Scholar
• 44 Armada M, Love S, Barrett E et al.. Foodborne botulism in a six-month old infant caused by home-canned baby food.  Ann Emerg Med. 2003;  42(2) 226-229
  PubMedGoogle Scholar
• 45 MacDonald K L, Rutherford G W, Friedman S M et al.. Botulism and botulism-like illness in chronic drug abusers.  Ann Intern Med. 1985;  102 616-618
  CrossrefPubMedGoogle Scholar
• 46 Mandler R N, Maselli R A. Stimulated single-fiber electromyography in wound botulism.  Muscle Nerve. 1996;  19 1171-1173
  PubMedGoogle Scholar
• 47 Chang G Y, Ganguly G. Early antitoxin treatment in wound botulism results in better outcome.  Eur Neurol. 2003;  49 151-153
  CrossrefPubMedGoogle Scholar
• 48 Kudrow D B, Henry D A, Haska D A et al.. Botulism associated with Clostridium botulinum sinusitis after intranasal cocaine abuse.  Ann Intern Med. 1988;  109 984-985
  PubMedGoogle Scholar
• 49 Cherington M. Treatment of botulism and wound botulism. In: Balows A, DeHaan RM, Dowell VR, Guze LB Anaerobic Bacteria: Role in Disease. Springfield; Charles C. Thomas 1974: 287-294
  Google Scholar
• 50 Park J-B, Simpson L L. Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component.  Infect Immun. 2003;  71 1147-1154
  CrossrefPubMedGoogle Scholar
• 51 Cherington M. Botulism.  Semin Neurol. 1990;  10 27-31
  PubMedGoogle Scholar
• 52 Technical Briefs . Botulism: information from the World Health Organization.  J Environ Health. 2003;  65 51-52
  PubMedGoogle Scholar
• 53 Chia J K, Clark J G, Ryan C A, Pollack M. Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum .  N Engl J Med. 1986;  315 239-241
  PubMedGoogle Scholar
• 54 Kobayashi H, Fujisawa K, Saito Y et al.. A botulism case of a 12-year-old girl caused by intestinal colonization of Clostridium botulinum type Ab.  Jpn J Infect Dis. 2003;  56 73-74
  PubMedGoogle Scholar
• 55 Bakheit A M, Ward C D, McLellan D L. Generalised botulism-like syndrome after intramuscular injections of botulinum type A: a report of two cases.  J Neurol Neurosurg Psychiatry. 1997;  62 198
  PubMedGoogle Scholar
• 56 Bhatia K P, Munchau A, Thompson P D et al.. Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases.  J Neurol Neurosurg Psychiatry. 1999;  67 90-93
  PubMedGoogle Scholar
• 57 Tugnoli V, Eleopra R, Quatrale R et al.. Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis.  Br J Dermatol. 2002;  147 808-809
  CrossrefPubMedGoogle Scholar
• 58 Girlanda P, Vita G, Nicolosi C et al.. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system.  J Neurol Neurosurg Psychiatry. 1992;  55 844-845
  CrossrefPubMedGoogle Scholar
• 59 Lange D J, Brin M F, Warner C L et al.. Distant effects of local injection of botulinum toxin.  Muscle Nerve. 1987;  10 552-555
  PubMedGoogle Scholar
• 60 Olney R K, Aminoff M J, Gelb D J, Lowenstein D H. Neuromuscular effects distant from the site of botulinum neurotoxin injections.  Neurology. 1988;  38 1780-1783
  PubMedGoogle Scholar
• 61 Kessler K R, Skutta M, Benecke R. Long term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency.  J Neurol. 1999;  246 265-274
  CrossrefPubMedGoogle Scholar
• 62 Ross M H, Charness M E, Sudarsky L, Logigian E L. Treatment of occupational cramp with botulinum toxin: diffusion of toxin to adjacent noninjected muscles.  Muscle Nerve. 1997;  20 593-598
  PubMedGoogle Scholar
• 63 Dressler D, Benecke R. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis.  Eur Neurol. 2003;  49 34-38
  CrossrefPubMedGoogle Scholar
• 64 Dowell V R, McCrosky L M, Hatheway C L et al.. Coproexamination for botulium toxin and Clostridium botulinum .  JAMA. 1977;  238 1829-1832
  CrossrefPubMedGoogle Scholar
• 65 Cornblath D R, Sladky J T, Sumner A J. Clinical electrophysiology of infantile botulism.  Muscle Nerve. 1983;  6 448-452
  PubMedGoogle Scholar
• 66 Gutmann L, Bodensteiner J, Gutierrez A. Electrodiagnosis of botulism.  J Pediatr. 1992;  121 835
  PubMedGoogle Scholar
• 67 Fakadej A V, Gutmann L. Prolongation of post-tetanic facilitation in infant botulism.  Muscle Nerve. 1982;  5 727-729
  CrossrefPubMedGoogle Scholar
• 68 Girlanda P, Dattola R, Messina C. Single fibre EMG in 6 cases of botulism.  Acta Neurol Scand. 1983;  67 118-123
  PubMedGoogle Scholar
• 69 Schiller H H, Stalberg E. Human botulism studied with single-fiber electromyography.  Arch Neurol. 1978;  35 346-349
  CrossrefPubMedGoogle Scholar
• 70 Hughes J M, Tacket C O. “Sausage poisoning” revisited.  Arch Intern Med. 1983;  143 425-427
  CrossrefPubMedGoogle Scholar
• 71 Atabek M E, Yavuz H, Oran B et al.. Plasmapheresis as an adjunct treatment in severe botulism.  Intensive Care Med. 2002;  28 814
  CrossrefPubMedGoogle Scholar
• 72 Robinson R F. Management of botulism.  Ann Pharmacother. 2003;  37 127-131
  CrossrefPubMedGoogle Scholar
• 73 Vahdani P, Pourshafie M R, Aminzadeh Z. Treatment of two unusual cases of type A and E botulism following consumption of salted fish.  Intensive Care Med. 2002;  28 1189
  CrossrefPubMedGoogle Scholar
• 74 Amersdorfer P, Wong C, Smith T et al.. Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.  Vaccine. 2002;  20 1640-1648
  CrossrefPubMedGoogle Scholar
• 75 Nowakowski A, Wang C, Powers D B et al.. Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.  Proc Natl Acad Sci USA. 2002;  99 11346-11350
  CrossrefPubMedGoogle Scholar
• 76 Cherington M. Botulism. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE Neuromuscular Disorders in Clinical Practice. Boston; Butterworth Heinemann 2002: 942-952
  Google Scholar
• 77 Jankovic J, Vuong M A, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.  Neurology. 2003;  60 1186-1188
  CrossrefPubMedGoogle Scholar
• 78 Dodick D W. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.  Headache. 2003;  43 S25-S33
  CrossrefPubMedGoogle Scholar
• 79 Rohrich R J. Completing the cosmetic surgery cycles: it takes a village.  Plast Reconstr Surg. 1999;  103 585-587
  PubMedGoogle Scholar
• 80 Vaezi M F, Richter J E, Wilcox C M et al.. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomized trial.  Gut. 1999;  44 231-239
  CrossrefPubMedGoogle Scholar
• 81 Brisinda G, Maria G, Bentivoglo A R et al.. A comparison of injection of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure.  N Engl J Med. 1999;  341 65-69
  CrossrefPubMedGoogle Scholar
• 82 Maria G, Brisinda G, Civello I M et al.. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study.  Urology. 2003;  62 259-265
  CrossrefPubMedGoogle Scholar
• 83 Hallett M. One man's poison: clinical applications of botulinum toxin.  N Engl J Med. 1999;  341 118-120
  CrossrefPubMedGoogle Scholar
• 84 Eleopra R, Tugnoli V, Quatrale R et al.. Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysiological study by motor units counting.  Clin Neurophysiol. 2002;  113 1258-1264
  CrossrefPubMedGoogle Scholar
• 85 Brashear A, McAfee A L, Kuhn E R, Ambrosius W T. Treatment with botulinum toxin type B for upper-limb spasticity.  Arch Phys Med Rehabil. 2003;  84 103-107
  CrossrefPubMedGoogle Scholar
• 86 Turton K, Chaddock J A, Acharya K R. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility.  Trends Biochem Sci. 2002;  27 552-558
  CrossrefPubMedGoogle Scholar

Michael CheringtonM.D. 

Lightning Data Center, St. Anthony Hospital

4231 West 16th Avenue, Denver, CO 80204